Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia
about
Diffusion-Weighted Magnetic Resonance Imaging Reversal by Gene Knockdown of Matrix Metalloproteinase-9 Activities in Live Animal BrainsThe Role of Matrix Metalloproteinase Polymorphisms in Ischemic StrokeImplications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokePlasmatic markers for early diagnostic and treatment decisions in ischemic strokeVascular protection to increase the safety of tissue plasminogen activator for strokeOverexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain traumaInflammation and infection in clinical strokeDelayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental strokeInhibition of MMP-2 but not MMP-9 influences inner ear spiral ganglion neurons in vitro.Neuroprotective effects of lipoxin A4 in central nervous system pathologies.Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured ratsBlood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.Biomarkers and acute brain injuries: interest and limitsMolecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activatorMultiple molecular penumbras after focal cerebral ischemia.The blood-brain barrier in health and disease.The impact of comorbidity on survival after hemorrhagic stroke among dialysis patients: a nationwide population-based study.Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke.Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairmentActivation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke.Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System InflammationThe potential use of MMP inhibitors to treat CNS diseases.Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic strokeExtracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery.Heat shock protein 90 inhibition by 17-Dimethylaminoethylamino-17-demethoxygeldanamycin protects blood-brain barrier integrity in cerebral ischemic stroke.Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Matrix metalloproteases: underutilized targets for drug deliveryMultiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.Interferon-β Modulates Inflammatory Response in Cerebral IschemiaSystems Biology of Immunomodulation for Post-Stroke Neuroplasticity: Multimodal Implications of Pharmacotherapy and NeurorehabilitationMalvidin's Effects on Rat Pial Microvascular Permeability Changes Due to Hypoperfusion and Reperfusion Injury.Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis
P2860
Q22065143-086FC466-38BC-4909-A1EB-D7887B183970Q26741200-ABF6018F-FD96-4777-8F9B-06F6CDFA3A4DQ26766038-1679BACB-EF6C-4389-AF3C-7DFA7A47E476Q26781099-A4276901-A5A2-47FA-A3D7-B1D6B8103A4AQ26824338-28B1086B-034B-45D9-B950-8BF0D547954BQ28141561-0E1140E2-A1B6-4057-9DB1-ADEF5AF6E586Q28194382-E4F8308E-8AB3-48B6-8F93-110184149683Q28569418-5592E649-21EA-4656-980B-F073875FB4ABQ30414848-8C5CD3B9-FF9F-4929-A321-8FFC2AC4C14FQ30857083-EE2383AB-BE48-4B1F-9481-9A9EC00151BEQ30924126-1ECB41A6-8F53-4AAB-91B1-D0AB24410C2CQ33684529-43B360BF-DF01-4C15-A5BE-C1C34E3440D2Q33752053-7A9988EE-D458-4915-822F-B0DFA1BFAE4EQ33823616-9F3BB716-FB12-4DEB-B640-E0B6653D0DBEQ33977693-019E00C1-5F77-480B-BEE5-093809570FC3Q34320420-19D0BBE8-4C03-4BC6-B562-750B1E3CA0BBQ34636747-B2DB93F7-EDDF-43EF-BBBD-2D9762D2A13BQ35027278-3D8B6A79-C47C-43C1-8F2C-754BB30D085DQ35042229-23ACCD10-232D-4C63-A203-6606AF88B91BQ35059041-23C81883-8726-4788-BB80-C540D93BAB9CQ35240865-2DB51962-2066-4679-B932-F8CF7CE33713Q35552443-645A09E6-DBA2-437C-8991-CC8308AA6B45Q35627073-85A6FB11-3919-4C2A-A681-886672DDD196Q35861206-CA338D0D-7516-484A-9BB7-82DEF3096D7CQ35907961-5CA4C948-CE15-4536-A802-24E288F582DAQ35939162-37F6083A-6210-4C58-80E6-2F11069F09DCQ36109112-2AF6E389-2161-417A-8B9C-2084597BDCDFQ36181275-1E4869B3-CEAE-4DF7-BF40-571DAB244AABQ36195297-E3B3F605-5EB5-426C-9093-5090B18FEDAAQ36307057-BF1C8233-A340-40A9-B351-B8595450B873Q36309484-9CFA0B71-BFAB-4144-8C33-80C13948DBD0Q36351793-86AD13B3-7F7B-450B-B896-203F049DC88FQ36644315-52519BCD-99A2-4242-8F48-48EF33BE2A22Q36736442-8761E3E0-1A16-4D87-B542-6B57D12B21F0Q36761849-FA878B2D-3A86-491E-8DBC-70CDF807E3D8Q36839585-03A5C132-07BF-4392-82F7-7AFFF47A809FQ36877674-DC09EA7F-40EF-4C55-8E21-ED2D95E88313Q37043237-1EF86F13-066A-4A44-8EB9-29442DCCF158Q37053366-FBC8783A-A9E9-4C5B-A04C-E65EBA11D64BQ37194323-9FBBDD16-7F6C-45DD-9D18-FCCA3D4872FD
P2860
Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@ast
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@en
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@nl
type
label
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@ast
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@en
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@nl
prefLabel
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@ast
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@en
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@nl
P2093
P3181
P1433
P1476
Increased gelatinase A (MMP-2) ...... man brain after focal ischemia
@en
P2093
C A Krekoski
D R Edwards
K R Chapman
P3181
P356
10.1016/S0304-3940(97)00859-8
P407
P577
1997-11-28T00:00:00Z